Determination of the relationship between CD34+stem cell amount and DMSO in hematopoetic stem cell transplantation

被引:0
|
作者
Meric, Neslihan [1 ,4 ]
Parmaksiz, Ayhan [2 ]
Gulbas, Zafer [3 ]
机构
[1] Kutahya Hlth Sci Univ, Fac Engn & Nat Sci, Dept Mol Biol & Genet, Kutahya, Turkiye
[2] Istanbul Hlth & Technol Univ, Fac Med, Istanbul, Turkiye
[3] Anadolu Hlth Ctr, Bone Marrow Transplantat Ctr, Kocaeli, Turkiye
[4] Kutahya Hlth Sci Univ, Fac Engn & Nat Sci, Dept Mol Biol & Genet, Evliya Celebi Yerleskesi Tavsanli Yolu 10 Km, TR-43100 Kutahya, Turkiye
关键词
DMSO (dimethyl sulfoxide); Hematopoietic stem cell transplantation; (HSCT); Cryopreservation; CD34+SCs count; Apheresis product (AP); PERIPHERAL-BLOOD PROGENITOR; DIMETHYL-SULFOXIDE; HEMATOPOIETIC ENGRAFTMENT; CRYOPRESERVATION; PREDICTOR;
D O I
10.1016/j.trim.2023.101831
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
It is important to calculate the CD34+ stem cell (SC) count at the right time in patients with hematological malignancies who will undergo Hematopoietic Stem Cell Transplantation (HSCT). The amount of SC infused into the patient affects the engraftment time and healing process of the patient. In this study, we aimed to compare which of the DMSO-not removed and DMSO-removed samples showed the CD34 + SC amount more accurately as the SC amount determination method after the SC was dissolved after cryopreservation in patients who will undergo HSCT. A total of 22 patients were included in the study. All 22 patients were transplanted from frozen samples using DMSO. After the SC products were dissolved in a 37 degrees C water bath, they were washed 2 times and the amount of CD34+ SC was studied from the samples taken by removing DMSO and without removing DMSO. In the findings, the amounts of CD34+ SC studied with both methods were compared. The increase in the number and percentage of CD34+ SC after DMSO-removed was found to be statistically significant both in terms of difference and proportionally, and the calculated effect sizes also showed that the increase was clinically significant (Cohen's d is between 0.43 and 0.677). After thawing the frozen SCs of the patients who will undergo HSCT, the analysis of CD34+ SCs from which DMSO is removed provides a more accurate calculation of the CD34+ SC amount in the AP.
引用
收藏
页数:5
相关论文
共 50 条
  • [31] CD-34 selected hematopoetic stem cell transplantation from HLA identical family members for fanconi anemia
    Balci, Yasemin Isik
    Akdemir, Yasemin
    Gumruk, Fatma
    Cetin, Mualla
    Arpaci, Fikret
    Uckan, Duygu
    [J]. PEDIATRIC BLOOD & CANCER, 2008, 50 (05) : 1065 - 1067
  • [32] Promise of autologous CD34+stem/progenitor cell therapy for treatment of cardiovascular disease
    Prasad, Megha
    Corban, Michel T.
    Henry, Timothy D.
    Dietz, Allan B.
    Lerman, Lilach O.
    Lerman, Amir
    [J]. CARDIOVASCULAR RESEARCH, 2020, 116 (08) : 1424 - 1433
  • [33] CD34+cells in hematopoietic stem cell transplantation
    Demirer, T
    [J]. TISSUE ENGINEERING, STEM CELLS AND GENE THERAPIES, 2003, 534 : 107 - 118
  • [34] DIABETES IMPAIRS CD34+STEM CELL MOBILIZATION IN PATIENTS WITH CHRONIC HEART FAILURE
    Poglajen, Gregor
    Sever, Matjaz
    Mali, Polona
    Haddad, Francois
    Wu, Joseph C.
    Vrtovec, Bojan
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 63 (12) : A863 - A863
  • [35] AUTOLOGOUS CD34+STEM CELL INFUSION AS A BRIDGE TO LIVER TRANSPLANT IN DECOMPENSATED CIRRHOSIS
    Sharma, M.
    Mitnala, S.
    Rao, P. N.
    Reddy, D. N.
    [J]. JOURNAL OF HEPATOLOGY, 2015, 62 : S347 - S347
  • [36] Poor Mobilization of CD34+Stem Cells Predicts Inferior Relapse and Survival Outcomes After Autologous Stem Cell Transplantation for Multiple Myeloma
    Lazaryan, Aleksandr
    Duong, Hien
    Rybicki, Lisa
    Reu, Frederic J.
    Dean, Robert
    Sobecks, Ronald
    Tench, Shawnda
    Copelan, Edward A.
    Kalaycio, Matt
    Bolwell, Brian J.
    [J]. BLOOD, 2011, 118 (21) : 1292 - 1292
  • [37] The kinetics of immune reconstitution after cord blood transplantation in children: comparison with bone marrow transplantation and selected CD34+stem cell transplantation
    Kato, S
    Yasuda, Y
    Inoue, Y
    Yabe, H
    Sako, M
    [J]. EXPERIMENTAL HEMATOLOGY, 2002, 30 (06) : 57 - 57
  • [38] Allogeneic Stem Cell Transplantation for Advanced Myelodysplastic Syndrome: Comparison of Outcomes between CD34+ Selected and Unmodified Hematopoietic Stem Cell Transplantation
    Tamari, Roni
    Oran, Betul
    Hilden, Patrick
    Maloy, Molly
    Kongtim, Piyanuch
    Papadopoulos, Esperanza B.
    Rondon, Gabriela
    Jakubowski, Ann A.
    Andersson, Borje S.
    Devlin, Sean M.
    Ahmed, Sairah
    Popat, Uday R.
    Ponce, Doris
    Chen, Julianne
    Sauter, Craig
    Young, James W.
    de Lima, Marcos
    Perales, Miguel-Angel
    O'Reilly, Richard J.
    Giralt, Sergio A.
    Champlin, Richard E.
    Castro-Malaspina, Hugo
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (05) : 1079 - 1087
  • [39] Gene expression and epigenetic profiling of CD34+stem cells in multiple sclerosis patients and healthy donors - implications for autologous hematopoietic stem cell transplantation
    Jelcic, I.
    Lutterotti, A.
    Schulze, C.
    Schippling, S.
    Mazzanti, B.
    Sputtek, A.
    Saccardi, R.
    Sospedra, M.
    Zander, A.
    Martin, R.
    [J]. ALLERGOLOGIE, 2011, 34 (02) : 118 - 118
  • [40] Effects of irradiation and hematopoetic stem cell transplantation on airway hyperreactivity
    Jones, J. C.
    Donaldson, S. S.
    Knox, S. J.
    Meyer, E. H.
    Umetsu, D. T.
    DeKruyff, R. H.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 69 (03): : S39 - S39